For the quarter ended September 2024, Teladoc (TDOC) reported revenue of $640.51 million, down 3% over the same period last year. EPS came in at -$0.19, compared to -$0.35 in the year-ago quarter. The reported revenue represents a surprise of +1.59% over the Zacks Consensus Estimate of $630.5 million. With the consensus EPS estimate being -$0.29, the EPS surprise was +34.48%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...

Teladoc (TDOC) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 34.48%. A quarter ago, it was expected that this telehealth services provider would post a loss of $0.36 per share when it actually produced a loss of $0.28, delivering a surprise of 22.22%.Over the last four quarters, the company ...

Revenue Performance - Third Quarter 2024 revenue of $640.5 million, down 3% year-over-year[2] - Revenue for Q3 2024 decreased by 3% to $640.5 million compared to $660.2 million in Q3 2023[24] - Nine Months Ended September 30, 2024 revenue decreased 1% to $1,929.1 million from $1,941.9 million in 2023[8] - Revenue for the nine months ended September 30, 2024, was $1.93 billion, slightly down from $1.94 billion in 2023[42] - U.S. revenue decreased 6% to $536.2 million, while International revenue grew 15% to $104.3 million[5] - U.S. Revenue declined by 6% to $536.2 million in Q3 2024, while International Revenue increased by 15% to $104.3 million[24] Segment Performance - Integrated Care segment revenue of $383.7 million, up 2% year-over-year, with adjusted EBITDA margin improved to 17.7%[2] - BetterHelp segment revenue of $256.8 million, down 10% year-over-year, with adjusted EBITDA margin of 5.9%[2] - Teladoc Health Integrated Care Revenue increased by 2% to $383.7 million in Q3 2024[29] - BetterHelp Total Revenue decreased by 10% to $256.8 million in Q3 2024[29] - Adjusted EBITDA for Teladoc Health Integrated Care increased by 8% to $68.0 million in Q3 2024[29] - Adjusted EBITDA Margin for BetterHelp decreased to 5.9% in Q3 2024 from 9.1% in Q3 2023[29] - Teladoc Health Integrated Care segment Adjusted EBITDA increased to $68.0 million in Q3 2024 from $62.8 million in Q3 2023[44] - BetterHelp segment Adjusted EBITDA decreased to $15.2 million in Q3 2024 from $25.9 million in Q3 2023[44] Net Loss and EBITDA - Third Quarter 2024 net loss of $33.3 million, or $0.19 per share[2] - Third Quarter 2024 adjusted EBITDA of $83.3 million, down 6% year-over-year[2] - Net loss for the nine months ended September 30, 2024, was $952.8 million, compared to $191.5 million in the same period in 2023[31] - Net loss for Q3 2024 was $33.3 million, compared to $57.1 million in Q3 2023, showing a 41.7% improvement[44] - Consolidated Adjusted EBITDA for Q3 2024 was $83.3 million, slightly down from $88.8 million in Q3 2023[44] Cash Flow and Capital Expenditures - Net cash provided by operating activities for the nine months ended September 30, 2024, was $207.8 million, down from $219.9 million in 2023[31] - Net cash provided by operating activities for the three months ended September 30, 2024, was $110.2 million, up from $105.6 million in 2023[33] - Free Cash Flow for Q3 2024 was $79.0 million, up from $68.0 million in Q3 2023[45] - Capital expenditures for Q3 2024 were $31.1 million, down from $37.6 million in Q3 2023[45] - Capitalized software development costs for the nine months ended September 30, 2024, were $89.8 million, down from $109.8 million in 2023[31] - Cash and cash equivalents at the end of the period were $1.24 billion, up from $1.03 billion at the end of 2023[31] Goodwill Impairment - Non-cash goodwill impairment charge of $790.0 million recorded in the first nine months of 2024, primarily related to the BetterHelp segment[9] - Goodwill impairment of $790.0 million was recorded in the nine months ended September 30, 2024, compared to none in 2023[31] Membership and Enrollment - U.S. Integrated Care Members expected to be 93.5 - 94.5 million for the full year of 2024[14] - U.S. Integrated Care Members increased by 4% to 93.9 million in Q3 2024[26] - Chronic Care Program Enrollment grew by 5% to 1.179 million in Q3 2024[26] - BetterHelp Paying Users decreased by 13% to 0.398 million in Q3 2024[27] - U.S. Integrated Care Members represent unique individuals with access to integrated care services at the end of the period[46] - Chronic Care Program Enrollment represents total enrollees across chronic care programs at the end of the period[48] - BetterHelp Paying Users represent the average number of global monthly paying users of therapy services[49] Total Visits and Adjusted Gross Profit - Total Visits decreased by 7% to 4.1 million in Q3 2024 compared to 4.4 million in Q3 2023[25] - Adjusted gross profit for the nine months ended September 30, 2024, was $1.37 billion, with an adjusted gross margin of 70.8%, consistent with 2023[42] Assets and Liabilities - Total assets as of September 30, 2024, were $3.53 billion, down from $4.39 billion at the end of 2023[34] - Total liabilities as of September 30, 2024, were $2.02 billion, down from $2.07 billion at the end of 2023[34] Business Segments Overview - The company operates two segments: Teladoc Health Integrated Care and BetterHelp, offering various virtual medical and therapy services[50] Future Expectations - For the fourth quarter of 2024, Integrated Care segment revenue growth expected to be 0% - 2.5% year-over-year, with adjusted EBITDA margin of 12.25% - 13.75%[14]

Wall Street analysts expect Teladoc (TDOC) to post quarterly loss of $0.29 per share in its upcoming report, which indicates a year-over-year increase of 17.1%. Revenues are expected to be $630.5 million, down 4.5% from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. Prior to a company's earnings announcement, it is crucial to co ...

In the latest trading session, Teladoc (TDOC) closed at $8.60, marking a -0.92% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.22%. At the same time, the Dow lost 0.33%, and the tech-heavy Nasdaq gained 0.76%.Heading into today, shares of the telehealth services provider had gained 2.48% over the past month, outpacing the Medical sector's loss of 3.79% and the S&P 500's gain of 1.47% in that time.Market participants will be closely following the financial result ...

If you'd like to learn more about how to best position yourself in under valued stocks mispriced by the market to start Q4, consider joining Out Fox The Street . Teladoc Health, Inc. (NYSE: TDOC ) is showing signs of hitting bottom after the company withdrew guidance following a big quarterly miss with the new CEO. The telehealth platform is still looking for the next growth catalyst, which could Mark leads the investing group Out Fox The Street where he shares stock picks and deep research to help readers ...

PURCHASE, NY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2024 results on Wednesday, October 30, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 781291. For internatio ...

Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "U.S. Direct To Consumer Telehealth Services Market Size, Share & Trends Analysis Report By Product (Remote Monitoring, Real-time Interactions), By Delivery Mode (Web-based, Cloud-based, On-premise), And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering. The U.S. direct to consumer telehealth services market size is expected to reach USD 9.53 billion by 2030, registering a CAGR of 30.3% during the forecast period The U.S ...

The market is underestimating the potential of the company, believes one pundit tracking its fortunes. Absent of any other stock-moving news, a 25% increase in an analyst's price target for Teladoc (TDOC 11.64%) got the stock moving northward on Tuesday. It ended up closing the day almost 12% higher on the move, for a much better performance than the essentially flat trajectory of the bellwether S&P 500 index. 25% more bullish News of the increase hit the headlines shortly before the market open. Jefferies ...

The latest trading session saw Teladoc (TDOC) ending at $7.25, denoting a +0.83% adjustment from its last day's close. The stock's performance was ahead of the S&P 500's daily gain of 0.45%. Elsewhere, the Dow lost 0.23%, while the tech-heavy Nasdaq added 0.84%. Shares of the telehealth services provider witnessed a gain of 4.66% over the previous month, beating the performance of the Medical sector with its gain of 3.16% and the S&P 500's gain of 2.54%. Analysts and investors alike will be keeping a close ...